European Companies Search Engine

UK funding (£601,387): Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR) Ukri 1 Nov 2008 UK Research and Innovation, United Kingdom

Overview

Text

Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR)

Abstract Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Category Collaborative R&D
Reference 100569
Status Closed
Funded period start 01/11/2008
Funded period end 31/10/2010
Funded value £601,387.00
Source https://gtr.ukri.org/projects?ref=100569

Participating Organisations

DNAE GROUP HOLDINGS LIMITED

£286,010.00

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

£271,035.00

PFIZER LIMITED

£44,342.00

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Dnae Group Holdings Ltd., London.